Navigation Links
Newly approved ocular safety methods reduce animal testing
Date:6/23/2008

Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today. ICCVAM is a permanent interagency committee composed of representatives from 15 federal regulatory and research agencies, including the National Institutes of Health (NIH) that use, generate or disseminate toxicology testing information.

The two alternative test methods, the bovine corneal opacity and permeability (BCOP) assay and the isolated chicken eye (ICE) assay, do not involve the use of live animals. These are the first scientifically valid alternative methods to gain regulatory acceptance for ocular safety testing.

The Consumer Product Safety Commission (CPSC), the Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA) concurred with the ICCVAM recommendations for the BCOP and ICE tests. CPSC will now accept these tests instead of the conventional ocular toxicity test for the purpose of classification for labeling under the Federal Hazardous Substance Act (15 U.S.C. 1261-1278).

"Based on an extensive database of product test results, the use of these two alternative test methods will likely reduce the use of live animals for eye safety testing by 10 percent or more," stated William Stokes, D.V.M., the executive director of ICCVAM and director of the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods NICEATM). "More importantly, the use of these tests will eliminate the testing in animals of most substances likely to cause the most severe pain and discomfort."

If a positive response is obtained using either of the two new approved alternative methods, the product can be labeled as causing irreversible or severe eye damage and no live animal testing will be required. If the response is negative, the product is
'/>"/>

Contact: Robin Mackar
rmackar@niehs.nih.gov
919-541-0073
NIH/National Institute of Environmental Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Worlds Leading Health Experts Urge Countries to Use Newly Released Data to Prevent the Death of Millions of Children Due to Rotavirus
2. IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE)
3. Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohns Patients
4. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
5. Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate
6. Newly diagnosed breast cancer patients benefit from use of USFNA of lymph nodes
7. WellPoints Health Plans to Cover Newly Approved Cancer Treatment
8. Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
9. Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... results in animals , , MONDAY, Nov. 3...uggest that stem cells from transplanted human-der...ng and heart disorders. , Scientists already k...long list of different kinds of cells in the labor...nter in Seoul, Korea, co-author of one of the stud...
(Date:11/30/2009)... Kemin Foods, L.C. ("Kemin") and Om...Health Technologies, Ltd. ("OmniActive") have reac...arties agree that Kemin,s US Patent No. 5,382,714 ... Purification and Recrystallization of Lutein from...nd the reissues of that patent are valid and enfor...
(Date:11/30/2009)...v. 30 During this time of year, pe...For a loved one with Alzheimer,s disease or other ...times struggle with appropriate gift items. ,, ...iders of senior living residences in the nation, i...hese suggestions. ,, A listening device with r...
(Date:11/30/2009)...y (EAU) and Europa Uomo, the European,advocacy mo... entered into an,affiliated partnership as part o...ve,patient awareness in Europe with regards to ur...sson, Secretary-General of the EAU: "Thanks to thi...will gain access to the latest information on,opt...
(Date:11/30/2009)...as launched a series of clinical trials in order t...t. This approach involves the application of perso...cells from the patient him or herself and designed...ve and frequent malignant tumours. The new therapy...d with the standard, first-line treatment involvin...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
...rch 7 IPC The,Hospitalist Company, Inc. (Nasdaq: ...y focused on the delivery of hospitalist medicine ...ts for its fourth quarter and,year-end 2007 on Thu...and will be hosted by Adam Singer,Chairman, Chief ...
...008--Worldwide, an average 95.4 percent of LASIK p...ding to the first review of the world body of scie...t and Refractive Surgery (ASCRS) announced today. ...onsidered among the most successful elective proce...
...matoid arthritis (RA),treatment market, held back ...d the withdrawal of Vioxx and Bextra, is reboundin...he market for prescription drugs to,treat RA toppe...rt by Kalorama Information, Worldwide Market for,R...
...ng Bi-Partisan Senate Letter, asks Lawmakers,to Re...ize Care, and Make,Reform Much More Difficult to A...e Oxygen Community, WASHINGTON, March 7 The Coun... to,approximately 650,000 chronically ill home oxy...
...evelopmental neurobiology at the Medical College o...holar in Neuroscience, has received the 2008 Mathi...e annual award, administered by Foundation for Adv...nce. , Dr. Mei will discuss his studies of neural...
...nic prescriptions in Michigan generated by ...T, March 7 According to new data released today,m...prescriptions written in,the state of Michigan in ...tion in the adoption and utilization of,ePrescribi...
Other Medicine News:Health News:IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results 2Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 2Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 3Health News:LASIK patients report more than 95 percent satisfaction rate worldwide 4Health News:In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market 2Health News:Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicare's Home Oxygen Benefit 2Health News:Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicare's Home Oxygen Benefit 3Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 2Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 3Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 2Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 3Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 4Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 5Health News:Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally 6
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Dr. Joce... and Intervention at George Washington University ...ow occult lesions identified with Breast-Specific ...lti-modality imaging for needle biopsy as well, as...l meeting of the Radiological Society of North Ame...
(Date:11/30/2009)..., , ATLANTA, Nov. 30 Amoe...urgery breast care products, is sponsoring the 4th...or the first time, Amoena will honor survivors and... by awarding a cabin for the one with the most ins...test, Amoena wants to hear about young mothers who...
(Date:11/30/2009)..., , INDIANAPOLIS, Nov. 30 /PRNewswir...ion (FDA) has approved Cymbalta® (duloxetine ...anxiety disorder (GAD) in adults, Eli Lilly and Co... generalized anxiety disorder can be a chronic ill...nts find a treatment option that is effective in b...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Early Bedtime May Help Stave Off Teen Depression 48337 1Early Bedtime May Help Stave Off Teen Depression 48337 2Early Bedtime May Help Stave Off Teen Depression 48337 3Herley Receives a 241 2 Million Contract Award for Complex Integrated Microwave Assemblies for U S Electronic Attack Aircraft 48334 1Herley Receives a 241 2 Million Contract Award for Complex Integrated Microwave Assemblies for U S Electronic Attack Aircraft 48334 2New study indicates radiologists need standards to ensure optimal visual accuracy 48331 1
... Combination of R7227, protease inhibitor, and R71...cant potency in reducing viral load in patients wi...if., and PRINCETON, N.J., April 25 Roche, InterMu... VRUS ) today announced the first results from t... acting antiviral (DAA) combination therapy for th...
...irst study evaluating DUROS(R) continuous delivery... , , HAYWARD, Calif., April 24 Intarcia Therapeu...nt accrual to a phase 1b clinical study evaluating...de). The study is being conducted at multiple cent...t of 44 patients with type 2 diabetes for a period...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: